CNMV Edison, 4 28006 Madrid

Barcelona (Spain), January 24, 2018

RELEVANT FACT

Dear Sir,

In accordance with the Article 228 of Royal Legislative Decree 4/2015, dated 23 October, which enacts the consolidated text of the Securities Market Act, LABORATORIO REIG JOFRE SA ("Reig Jofre" or "the Company") submits hereafter press release on the launch in France of a new nutritional supplement of its Forté Pharma brand.

Adolf Rousaud

Secretary of the Board of Directors Laboratorio Reig Jofre SA

FORTÉ PHARMA, REIG JOFRE'S NUTRITIONAL SUPPLEMENTS LINE, LAUNCHES IN FRANCE FORTÉ NUIT 8H

  • Forté Pharma

market

the natural,

effective

and

without

side effects

alternative

to

help to

fight sleep

disorders

Barcelona (Spain), January 24, 2018. Forté Pharma, Reig Jofre's nutritional supplements line, launched recently in France, its home market, Forté Nuit 8h, a new nutritional supplement that extends the health range and represents the natural alternative to help to fight sleep disorders.

Forté Nuit 8h improves the latency time, time period necessary to fall asleep and it also provides a quality rest for 8 hours, without drowsiness or side effects upon awakening and without causing dependence.

Forté Nuit 8h acts with a double effect thanks to its natural formula, the optimal dose of its ingredients and its original bilayer tablets format, which provides an immediate effect through the rapid melatonin release that favors the first phase of the sleep cycle, as well as, a long-acting effect thanks to the combination of natural extracts, valerian, passionflower and vitamins B3 and B6, which contribute to prolong sleep for 8 hours.

The health segment, growing in the market for nutritional supplements in France, reaches sales of more than 700 million euros, of which the sleep and stress products represent 170 million euros. Forté Pharma has in France more than 5,000 points of sale between pharmacies and parapharmacies.

Forté Pharma is planning Forté Nuit 8h's international expansion with the star of its marketing in Belgium during the first quarter of 2018.

Regarding the Spanish market, Forté Pharma plans to continue the development of the weight control segment during the first half of the year and to boost the rest of the categories on the second half.

Nowadays the portfolio of Forte Pharma is organized into four segments: energy (35% of its total sales), slimming (30%), health (22%) and beauty (13%) at the end of September 2017.

At present, the marketing of Forte Pharma products is conducted mostly in Europe through own sales network. Forte Pharma's home market, and still today the first market of the brand, is France, which concentrated 67% of sales, followed by Forte Pharma Iberica (Spain and Portugal) and Benelux, with 13% respectively, and 7% in the rest of the world.

Receive Reig Jofre's news by registering in the company's subscription center of the new corporate website:www.reigjofre.com

About Reig Jofre

Founded in 1929 in Barcelona, Reig Jofre is a pharmaceutical company focused on the research, development, manufacture and marketing of pharmaceutical products and nutritional supplements.

The company directs its R&D to develop new indications and/or dosage forms of known active principles, generic medicines with a special focus on beta-lactam and lyophilized injectable antibiotics, topical dermatological products, OTCs and nutritional supplements as well as the development of new innovative molecules in partnership with start-ups and research centers.

Reig Jofre has over 900 employees, 4 development and manufacturing centers in Europe (2 in Toledo, 1 in Barcelona and 1 in Sweden), direct sales in 7 countries and over 130 commercial partners in 64 countries worldwide. The company reached sales of €161 M in 2016.

Reig Jofre trades on the Spanish stock exchange under the ticker RJF. Total outstanding shares: 64,153,178 shares.

For further information

Media

Inma Santa-Pau

Tel. (+34) 93 480 67 10 - ext. 1242inma.santapau@reigjofre.com

Shareholder office

Patricia Casado

Tel. (+34) 93 480 67 10 - ext. 1237patricia.casado@reigjofre.com

2

Laboratorio Reig Jofre SA published this content on 24 January 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 24 January 2018 09:04:08 UTC.

Original documenthttp://www.reigjofre.com/images/descargas/eng/investors/relevant_facts/2018-01-24-HR-NdP-Lanzamiento-Forte-Nuit-8h-ing.pdf

Public permalinkhttp://www.publicnow.com/view/308FCF89A504B8505222E98BFEB4213DCCA68573